Poppins, a Paris, France-based neurotech startup, raised €5M in funding.
The round was led by Racine with participation from Bpifrance Patient Autonome fund, Eurazeo, Kurma Partners, BNP Paribas Développement, and Verve Ventures.
The company intends to use the funds to expand operations and its development efforts.
Founded in 2018 by François Vonthron and Antoine Yuen from the École Polytechnique, Paris, Poppins advances medical devices for the treatment of neurodevelopmental disorders, mainly dyslexia. Its video game app – built around rhythmic and auditory stimuli – offers home-based support to support and enhance speech therapy care.
FinSMEs
28/04/2025